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Involvement of gamma aminobutyric acid in the anticonvulsant 
effect of the leaf methanol extract of Ruta graveolens L. (Rutaceae) 
in mice 
A.H. Ahmad and G.J. Amabeoku 
Abstract: The possible involvement of gamma aminobutyric acid (GABA), in the 
anticonvulsant effect of Ruta graveolens  L. was investigated by studying the effect of 
the leaf methanol extract against seizures elicited by either pentylenetetrazole (PTZ), 
bicuculline, picrotoxin or N-Methyl-DL-Aspartic acid (NlvIDLA) in mice. Leaf 
methanol extract of Ruta graveolens, phenobarbitone, diazepam and muscimol 
significantly antagonized seizures induced by PTZ, bicuculline or picrotoxin. 
Combined treatment of sub- effective doses of R. graveolens and muscimol 
significantly antagonized seizures induced by PTZ, bicuculline or picrotoxin. 
Dimethylsulfoxide (DMSO) or phenytoin did not significantly affect the seizures 
produced by PTZ, bicuculline or picrotoxin. Ruta graveolens, phenobarbitone, 
diazepam, phenytoin or DMSO did not significantly affect seizures produced by 
NlvIDLA. LY233053 significantly antagonized seizures produced by NlvIDLA. 
Combined treatment of sub-effective doses of LY233053 and Ruta graveolens did not 
significantly alter NlvIDLA-induced seizures. The phytochemical qualitative analysis of 
the plant species showed the presence of tannins, cardiac glycosides, saponins, 
flavonoids, triterpene steroids and alkaloids. The LD50 value obtained following oral 
administration of the leaf methanol extract of R. graveolens was above 4000 mg kg-1 .
The HPLC fingerprint of the plant species revealed certain characteristic peaks at 350 
run. The data obtained in this study, indicate that the leaf methanol extract of R. 
graveolens has anticonvulsant activity. The data obtained also indicate that GABA 
mechanism may probably be involved in the anticonvulsant effect of the plant 
extract. The relatively high LD50 obtained for the plant species, given orally, indicates 
that it is safe in mice. 
Introduction 
Epilepsy is a worldwide neurological disorder which 1s also prevalent in South 
Africa. Besides the use of standard medicines to manage and treat the condition 
effectively, medicinal plants have been used especially in rural commmrities by 
traditional medicine practitioners to manage and treat epilepsy (Van Wyk  et  al., 
1997; Wat  1967).  One   of   such   medicinal   plants   is Ruta graveolens L.  
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The plant species originated from the Mediterranean region and is now well 
distributed worldwide (Watt and Breyer-Brandwijk, 1962). In South Africa, R. 
graveolens which belongs to the family of Rutaceae, is commonly grown as herbs in 
gardens and has become well established in some parts of the country such as the 
Calvinia District where it iswell known as a medicinal plant (Van Wyk et al., 1997; Rood, 
1994; Palmer and Pitman, 1972). Locally, R. graveolens is known as "wynruit or 
binnewortel" in Afrikaans and rue or herb of grace in English (Van Wyk et al., 1997). 
Ruta gravealens L. is a small evergreen, aromatic, woody perennial shrub of about a 
meter in height. The leaves are irregularly divided into several leaflets which are 
variable in size and shape. Clusters of small yellow flowers are found at or near the 
tips of the branches. Each flower has four yellow petals with irregularly toothed 
margins. The fruits of the plant species are small four lobed capsules which are 
heavily covered with glands (!auk et al., 2004; Van Wyk et al., 1997). Rue has been 
used as a medicinal herb for centuries. Leaf infusions are taken for fever, convulsions 
and fits in  children,  and  for  epilepsy  and  hysteria (Van Wyk et al., 1997; Watt, 
1967). Alcoholic tinctures have been used to  treat,  respiratory  problems  and heart 
diseases  (Ojala  et  al.,  2000;  Rood,  1994; Watt  and Breyer-Brandwijk, 1962). 
Decoctions have been used to ease child birth (Browner, 1985). Toothache and 
earache have been treated with briused   leaves  (Rood,  1994; Wat   1967;   Watt    and    
Breyer-Brandwijk,    1962). The plant is traditionally used in Europe for a wide range 
of aihnents, ranging from hysteria to rhewnatism (Atta and Alkofahi, 1998; Grieve, 
1967). Ithas been used as a contraceptive (Browner, 1985) and also to relieve 
symptoms of hang over (Atta and Alkofahi, 1998). Despite the wide use of Ruta 
graveolens by traditional medicine practitioners and homeopaths in the treatment 
and management of epilepsy (Van Wyk  et  al.,  1997; Grieve, 1967; Watt and Breyer-
Brandwijk, 1962), little or no information exists in any literature about studies on the 
possible mechanism of the anticonvulsant effect of the plant species. The main aim of 
this study was, therefore, to verify the anticonvulsant effect and also to investigate the 
possible mechanism involved of the leaf methanol extract of Ruta graveolens m mice. 
Phytochemical qualitative analysis, acute toxicity and HPLC studies of the plant 
species were also carried out. 
 
Materials and methods 
Plant material: Fresh leaves of Ruta graveolens L. were bought from the Nursery, 
Kirstenbosch Botanical Garden, South Africa, in February 2011. A sample of the 
collected leaves was identified by 1.1r F. Weitz, a taxonomist, in the Department of 
Biodiversity and Consenration Biology, University of the Western Cape and a voucher 
specimen (No. 6974) was deposited in the University's Herbarium. 
 
Preparation of the methanol plant extracts: Fresh leaves were separated from 
branches of the plant and weighed (222.5 g). They were then washed with distilled 
water, air dried for an hour and dried in an oven at 40°C for 2 days. The dried leaves 
were milled into coarse powder (177.6 g) using the hammer mill.  For the preparation 
of the leaf methanol  extract,  25  g  of  the  dried   powder   of Ruta graveolens was 
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extracted in a Soxhlet extractor with 500 mL of methanol for 5 h. The resultant 
methanol filtrate was evaporated to dryness using a Buchi RE 11 rotavapor and Buchi 
461 water bath. A yield of 6.3 g extract of crude methanol was obtained and presenred 
in a refrigerator. Fresh solution of the crude leaf methanol extract was prepared on 
each day of the experiment by dissolving a weighed quantity of the methanol extract 
in a small volume of dimethylsulfoxide (DMSO) and made up to the appropriate   
volwne with physiological saline. The solutions were administered intraperitoneally 
(i.p.) to mice in a volume of 1 mL/l 00 g of animals. 
 
Animals: Male albino mice bred in the Animal House of the Discipline of 
Pharmacology, School of Pharmacy, University of the Western Cape, South Africa, 
weighing between 18 g and 30 g were used in groups of eight per dose of plant extract 
or drug. They had free access to food and water ad libitum.  All animals were fasted 
for 16 h. during which they had access to water prior to the commencement of the 
experiments. Laboratory condition of temperature (25±1°C) humidity and a 12 h. 
light/12 h dark cycle were maintained at all times during the experiments. Each 
mouse was used only once in the experiments. 
 
Drugs and chemicals: Pentylenetetrazole (PTZ, Sigma Chemical Co.), picrotoxin 
(Sigma Chemical Co.), N-methyl-DL-aspartic acid (NMDLA, Sigma Chemical Co.), 
phenobarbitone sodium (BDH Chemicals Ltd), 5,5 diphenylhydantoin sodium salt 
(Phenytoin, Sigma Chemical Co.), muscimol (Sigma Chemical Co.) and LY233053 
(Sigma Chemical Co.) were all dissolved in physiological saline to appropriate 
volwnes. (+) Bicuculline (Sigma Chemical Co.) was suspended in a small volume of 
Tween 80 and adjusted to the appropriate volume with physiological saline. Diazepam 
(Valiwn, Roche, South Africa) was dissolved in a minimwn amount of propylene glycol 
and made up to the appropriate volwne with physiological saline. Dimethylsulfoxide 
(DMSO, Sigma Chemical Co.) solution was prepared by dissolving equal volwne, used 
to dilute the plant extract, in an appropriate volume of physiological saline. All drugs 
were injected intraperitoneally (i.p.) in a volwne of 1 mL/l 00 g of animal. Equal 
volume injections of the appropriate vehicles such as physiological saline and DMSO 
were given to the control animals. The plant extract and drug solutions were prepared  
fresh  on the days of the experiment. The doses and pre-treatment times of the leaf 
methanol extract and the standard antiepileptic drugs used were obtained from 
preliminary studies in laboratory. The pre-treatment times following the 
administration of pentylenetetrazole, bicuculline, picrotoxin or NlvIDLA were 15 min 
(plant extract), 10 min (phenobarbitone ), 20 min (diazepam), 20 min (phenytoin), 30 
min (LY233053), 1 h (muscimol) and 15 min (DMSO solution). 
 
Phytochemical qualitative analysis: The dried powdered leaf of the plant species 
was analysed for various chemical compounds using standard protocols and well 
established methods (Ikhiri et al., 1992; Harbome,  1984). 
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HPLC analysis 
Chromatographic system: Beckman HPLC consisting of double pump   
Programmable system Solvent Module model 126; Diode Array detector module model 
160; Samstmg computer 386 with management System Gold (Gold V 601) software 
applied by Beckman; column. Cl 8 Bondapak 5 µrn and dimentions (250x 4.6 mm'). 
 
Chromatographic conditions: Mobile phase, solvent A: 1% acetic acid; solvent B: 
methanol, Mode: gradient flow rate, 1 min min-1 ; injection volwne, 10 µL; detector, 
lN at 350 nm. The HPLC operating conditions were programmed to give the following: 
0 min, solvent B: 20%; 5 min, solvent B: 40%; 15min, solvent B: 60%; 20 min, solvent 
B: 80% and 27 min. The run rate was 30 min. 
 
Anticonvulsant activity assessment: The method described by Vellucci and 
Webster (1984) and modified by Arnabeoku and Chikuni (1993), was used to assess the 
anticonvulsant activity of the leaf methanol extract  of Ruta graveolens. The mice were 
kept singly in transparent perspex mice cages 30 min before the start of the 
experiment to get used to their new environment. Control animals were pretreated for 
15 min with physiological saline (0.25 mL, i.p.) and then standard convulsant agents, 
such as,  PTZ  (95  mg  kg-',  i.p.),  bicuculline (40 mg kg-', i.p.), picrotoxin (12 mg kg-', 
i.p.) or NMDLA (400 mg kg-1, i.p.) was administered to induce convulsion in the mice. 
The animals ere obsenred for 30 min for tonic convulsion. Seizures were manifested as 
tonic hind- limb extensions. The time of the onset of seizures and proportion of 
animals convulsing or not convulsing were obtained during the 30 min period of 
obsenration. Test animals,  eight  per  group,  were pre-treated with either the  leaf  
methanol  extract  of  the   plant   species (25-100 mg  kg-',  i.p.),  phenobarbitone (l2 
mg kg-', i.p.), diaz.eparn (0.5 mg kg-', i.p.), phenytoin (30 mg kg-', i.p.), muscirnol   
(0.6-2   mg    kg-',    i.p)    or    LY233053 (1-5 mg kg-', i.p.) prior to the adininistration 
of any of the convulsant agents. The animals were also obsenred for 30 min for tonic 
convulsion. The time of the onset of seizures and proportion of animals convulsing or 
not convulsing were obtained during the 30 min period of obsenration. The 
experiment was repeated with another group of eight mice pretreated for 15 min with 
DMSO (0.25 mL, i.p.) prior to the adininistration of any of the convulsant agents. 
The ability of the plant extract to prevent or prolong the latency or onset of the tonic 
hind limb extensions was taken as an indication of anticonvulsant activity (Amabeoku 
and Chikuni, 1993; Amabeoku et al., 1998). All the experiments were carried out in a 
quiet laboratory at an ambient temperature of 25±1°C and between 8.30 arn-17.00 pm 
on each a day of the experiment. 
 
Acute toxicity study: The modified methods of Lorke (1983) by Ojewole (2006) 
and El Hilaly et al. (2004) were used  for the  acute toxicity  study of R. graveolens.  
The acute toxicity study was carried out to establish the median lethal dose (LD50 ) 
of the plant extract. Mice were fasted for 16 hours and then randomLy  divided into 
groups of eight mice per cage . Graded doses of the plant extract (l 00, 200, 400, 800, 
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1200, 1600, 2000, 2400, 2800, 3200, 3600 and 4000 mg kg-') were separately 
administered orally by means of a bulbed steel needle to mice  in each test  group.  
The control group received 0.25 mL (p.o.) of physiological saline by means of a 
bulbed steel needle. The mice were then allowed free access to food and water and 
obsenred for 5 days for signs of acute toxicity including death. If necessary, at the end 
of the 5 days obsenration period, log dose-response cwves would be constructed for 
the plant extract from which the median lethal dose would be calculated. 
 
Statistical Analysis: The data on the onset of tonic convulsion were analysed using one 
way analysis of Variance (ANOVA) followed by Dunnett's multiple comparison test (Graph 
Pad Prism, version 5.0, Graph Pad software, Inc., San Diego Cap 2130, USA). The number 
of animals convulsing was analysed using  the  chi-squared test (Bienvenu et al., 2002). 
The data obtained were expressed as Mean±SEM. P values  of  less  than  5% (p<0.05) were  
considered  statistically  significant  . 
 
Ethical consideration: The experimental protocol used in this study was approved 
(07/04/31) by the Uinversity of the Western Cape Ethics Committee, Bellville 7535, 
South Africa and conforms with the University's Regulations Act concerning animal 
experiments. 
 
Results 
Phytochemical analysis: The qualitative phytochemical analysis of the dried 
powdered leaf of Ruta graveolens showed that the chemical constituents in the  plant 
species include tannins, saponins, cardiac glycosides, alkaloids, flavonoids and 
triterpene steroids. 
 
Anticonvulsant activity 
Effect of leaf methanol extract of Ruta graveolens on pentylenetetrazole 
(ptz)-induced seizures: Pentylenetetrazole (PTZ, 95 mg kg-', i.p.) produced tonic 
convulsion in 100% of the animals tested. Leaf methanol extract of Ruta graveolens 
(25-50 mg kg-', i.p.) did not significantly affect the onset or incidence of the tonic 
convulsion elicited by  PTZ  (95  mg  kg-',  i.p.).  Doses of 25 and 50  mg  kg-'  (i.p.)  of  
R.  graveolens protected  25  and  37.5%  of   the   mice   against PTZ (95 mg kg-1, i.p.)-
induced tonic  convulsion,  respectively. 
 
The onset  of  the  tonic  convulsion  produced  by PTZ (95   mg   kg-',    i.p.)    was    
significantly  prolonged by R. graveolens (100 mg kg-', i.p.). The number of animals 
convulsing as a result of PTZ (95 mg kg-1 , i.p.) was  also  significantly  reduced   by   
R. graveolens (100 mg kg-', i.p.) which protected 62.5% of the animals against the 
seizures. Phenobarbitone (12 mg kg-1, i.p.) and muscimol (2 mg kg-1 , i.p.) significantly 
delayed the onset of PTZ (95 mg kg-', i.p.)-elicited tonic convulsion  and also 
significantly reduced the number of animals convulsing as a result of the tonic 
convulsion. Phenobarbitone   (12   mg   kg-',    i.p.)    and  muscimol (2 mg kg-', i.p.) 
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protected 75 and  87.5%  of mice against the tonic  convulsion,  respectively.  
Diazeparu (0.5 mg kg-', i.p.) completely protected all the animals used against PTZ (95 
mg kg-', i.p.)-elicited tonic convulsion. Like leaf methanol extract of R. graveolens (25 
mg kg-', i.p.), muscimol (0.6 mg kg-', i.p.) did not significantly affect the onset or 
incidence of the 10 tonic convulsion elicited by PTZ  (95 mg kg-', i.p.). Muscimol (0.6 
mg kg- 1,  i.p.) protected 25 of mice against the tonic convulsion. However, combined 
therapy of leaf methanol extract of R. graveolens (25 mg kg-1, i.p.) and muscimol (0.6 
mg kg-', i.p.) significantly prolonged the onset of the tonic convulsion produced by 
PTZ (95 mg kg-', i.p.) and significantly reduced the number of animals convulsing. 
The combined therapy protected 87 .5% of the animals against the tonic convulsion. 
DMSO (0.25 mL, i.p.) or phenytoin (30 mg kg-', i.p.) did not significantly affect the 
onset or incidence of the tonic convulsion elicited by PTZ (95 mg kg-', i.p.) (Table 1). 
 
Effect of leaf methanol extract of Ruta graveolens on bicuculline-
induced seizures: Bicuculline (40 mg kg-1 , i.p.) induced tonic convulsion in all 
the eight mice used for the experiment. Leaf methanol extract of R. graveolens (100 
mg kg-', i.p.) significantly  delayed the onset of bicuculline (40 mg kg-1,  i.p.)-
induced tonic convulsion and  also  significantly  reduced  the  nwnber  of  animals 
convulsing. R. graveolens (100 mg kg-1, i.p.) protected 75% of the animals against 
the convulsion produced by bicuculline (40 mg kg-', i.p.). Similarly, 50 mg kg-' (i.p.) of 
R. graveolens significantly delayed the onset of the tonic convulsion elicited by 
bicuculline (40 mg kg-1, i.p.). However, the incidence of the tonic convulsion was not 
significantly affected by R.graveolens (50 mg kg-', i.p.) which  protected  50%  of  m 
ice against  the  convulsion. 
 
R. graveolens (25 mg kg-1, i.p.) neither significantly altered  the  onset  nor  the   
incidence   of  bicuculline (40 mg kg- 1, i.p.)-elicited tonic convulsion. Phenobarbitone 
(12 mg kg-', i.p.), diazeparu (0.5 mg kg-', i.p.) or muscimol (2 mg kg-', i.p.) significantly 
delayed the onset  of  tonic  convulsion  produced   by  bicuculline (40 mg kg-', i.p.) 
and also significantly reduced the nwnber of animals convulsing. Phenobarbitone (12 
mg kg-', i.p.), diazeparu (0.5 mg kg-', i.p.) or muscimol (2  mg   kg-',   i.p.)   protected   
87.5%   of  mice   against bicuculline (40 mg kg- , i.p.)-elicited  tonic  convulsion. 
 
Neither phenytoin (30 mg kg-', i.p.), DMSO (0.25 rnL, i.p.) nor muscimol (0.6 mg kg-1 , 
i.p.) significantly altered the onset or incidence of bicuculline (40 mg kg-1 , i.p.)- 
induced tonic convulsion. The combined therapy of leaf methanol extract of R. 
graveolens (25 mg kg-', i.p.) and muscimol (0.6 mg kg-', i.p.) significantly delayed the 
onset of the tonic  convulsion  produced  by bicuculline (40 mg kg-', i.p.) and 
significantly reduced the number of animals convulsing. The combined therapy 
protected 62.5% of the animals against the tonic convulsion (Table 2). 
 
http://repository.uwc.ac.za
7 
 
Effect of leaf methanol extract of Ruta Graveolens (RG) on picrotoxin 
(PIC)-induced seizures: Picrotoxin (15 mg kg-1, i.p.) produced tonic convulsion   
within 10.75 min in all the mice used. Leaf methanol extract of Ruta graveolens (50-
100 mg kg-', i.p.) significantly prolonged the onset of the tonic convulsion produced by 
picrotoxin (15 mg kg-', i.p.). 
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These doses of the plant extract also significantly reduced the number of animals 
convulsing. R. graveolens (50 mg kg-1, i.p.) and (J OO mg kg-', i.p.) protected 62.5 and 
100% of mice against picrotoxin-induced tonic convulsion,  respectively. Dose of  25 mg  kg-
',  i.p.)  of   the  leaf   methanol   extract  of R. graveolens did not significantly affect the 
onset or incidence of picrotoxin (15 mg kg-1, i.p.)-induced tonic convulsion. 
Phenobarbitone (12 mg kg-1, i.p.), diazeparu (0.5 mg kg-', i.p.) or muscimol (2 mg kg- ,' 
i.p.) significantly delayed the onset of tonic convulsion produced by picrotoxin (15 mg kg-', 
i.p.) and also significantly reduced the number of animals convulsing. Muscimol (0.6 mg 
kg-', i.p.) did significantly alter the onset or incidence of picrotoxin (15 mg kg-1, i.p.)-
induced tonic convulsion. but protected 37 .5% of mice against the tonic convulsion. 
However, the combined therapy of leaf methanol extract of R. graveolens (25 mg kg-', 
i.p.) and muscimol (0.6 mg kg-', i.p.) significantly delayed the onset of the tonic convulsion  
produced  by  picrotoxin (15 mg kg-', i.p.) and significantly reduced the number of animals  
convulsing. The combined therapy protected 75% of the animals against the tonic 
convulsion. DMSO (0. 25 mL, i.p.) or phenytoin (30 mg kg-', i.p.) did not significantly 
affect the onset or incidence of picrotoxin (15 mg kg-', i.p.)-induced tonic convulsion 
(Table 3). 
 
Effect of leaf methanol extract of Ruta graveolens (RG) On N-methyl-DL 
aspartic acid (NMDLA)-induced seizures: NlvIDLA (400 mg kg-1, i.p.) produced 
tonic convulsion within 2.63 min in 100% of mice used. In all the doses (25-100 mg kg-', 
i.p.) used, the leaf methanol extract of R. graveolens did not significantly affect the onset 
of NlvIDLA (400 mg kg-1 , i.p.)-induced tonic convulsion or the nwnber of animals 
convulsing.  Phenobarbitone (12 mg kg-', i.p.), diazeparu (0.5 mg kg-', i.p.), phenytoin (30 
mg kg-', i.p.) or DMSO (0.25 mL, i.p.) also did not significantly affect the onset of 
NMDLA (400 mg kg-', i.p.)-induced tonic convulsion or the number of animals 
convulsing. LY 233053 (5 mg kg-', i.p.) significantly prolonged the onset of the tonic 
convulsion produced by NMDLA (400 mg kg-', i.p.) and significantly reduced the number 
of animals convulsing. Dose of 5 mg kg-1 (i.p.) of LY 233053 protected 87.5% of mice 
against NMDLA (400 mg kg-', i.p.)-induced tonic convulsion.  LY 233053 (I mg kg-', i.p.) 
did not significantly affect the onset or incidence of NMDLA (400 mg kg-', i.p.)-
induced tonic convulsion. 
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Furthermore, the combined treatment of the leaf methanol extract of R. graveolens 
(I00 mg kg-', i.p.) and LY233053 (I mg kg-', i.p.) also did not significantly affect the 
onset or incidence of the tonic convulsion produced by NMDLA (400 mg kg-', i.p.) 
(Table 4). 
 
Acute toxicity: The doses of 100-4000 mg kg-' (p.o.) of the leaf methanol extract of 
Ruta graveolens caused no deaths and there were no signs of acute toxicity. Since the 
highest dose tested was 4000 mg kg-' (p.o.), this is taken as the no-adverse-effect-level 
(NOAEL). The LD50 obtained for R. graveolens following oral administration was 
probably greater than 4000 mg kg-1  in mice. 
 
HPLC analysis: The chromatographic spectrum of the leaf methanol extract of Ruta 
graveolens obtained revealed major characteristic peaks at the following retention 
times (mni):  1.654, 2.271, 2.403, 4.705 and 7.691 min (Fig. 1). 139 
 
Discussion 
The study investigated the anticonvulsant effect of the leaf methanol extract of R. 
graveolens inmice and the possible involvement of GABA. 
 
In  this  study,  PTZ  (95  mg   kg-',   i.p.), bicucullnie (40 mg kg-', i.p.), picrotoxni (15 
mg kg-', i.p.) and NMDLA (400 mg kg-', i.p.) all produced tonic convulsions inthe 
mice used. The leaf methanol extract of Ruta graveolens (50-100 mg kg-', i.p.) 
antagonized the tonic convulsions produced by PTZ, bicuculline and picrotoxin but 
did not affect NlvIDLA-induced tonic convulsion. Similarly, phenobarbitone (12 mg kg-
1, i.p.), diazepam (0.5 mg kg-', i.p) and muscimol (2 mg kg-',i.p.) antagonized the 
tonic convulsions produced by PTZ, bicuculline  and  picrotoxin  but   did  not  affect  
the tonic convulsion  produced   by   NlvIDLA.  Phenytoin (30 mg kg-1, i.p.) did not 
affect the tonic convulsions produced  by  either  of  the   four   convulsant  agents. LY 
23350 (5 mg kg-', i.p.) antagonized NMDLA-niduced tonic convulsion. 
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According to Meldrum (1975), Olsen (1981), Czuczwar and Patsalos (2001 ), Waller et 
al. (2005) and Rang et al. (2012), gamma amniobutyric acid (GABA), a major 
inhibitory neurotransmitter, with its receptors, GABAA receptors and glutamic acid, 
an  excitatory neurotransmitter with its receptors, NlvIDA receptors in the brain may 
be implicated in epilepsy. They reported that the enhancement and inhibition of 
GABA mediated inhibition at GABAA receptors in the brain antagonizes and causes 
convulsion, respectively. They also reported that the enhancement and inhibition of 
glutamic acid neurotransmission at NlvIDA receptors in the brain enhances and 
antagonizes convulsion, respectively. According to Rang et al. (2012) and De Sano et al. 
(1999), pentylenetetrazole acts by blocking GABAA receptors thus inhibiting GABA 
mediated inhibition. Phenobarbitone   and   diazepam,   standard   antiepileptic drugs 
(Rang et al., 2012; Waller et al., 2005) are known to act by enhancing GABA 
neurotransmission in the brain through the GABAA receptor-chloride ionophore 
complex. In the present study, phenobarbitone and diazepam antagonized PTZ-
induced tonic convulsion and this may probably be as a result of their enhancing 
GABA neurotransmission. Phenytoin, another standard anticonvulsant, did not 
antagonize the tonic convulsion produced by PTZ. According to Rang et al. (2012) and 
Waller et al. (2005), phenytoin produces its antiepileptic effect by blocking the entry of 
sodium ions into brain cells and thus, inhibiting the generation of repetitive action 
potential. Muscimol effectively antagonized PTZ-induced tonic convulsion in mice. 
Muscimol, a selective and powerful GABAA receptor agonist, acts by interacting with 
GABAA receptors inthe brain to mimic the effects of GABA (Rang et al., 2012; Lloyd, 
1985). The leaf methanol extract of R. graveolens was shown to antagonize the tonic 
convulsion produced by PTZ. It is therefore, possible to suggest that R. graveolens 
may be affecting GABA mechanism to produce its anticonvulsant activity. The 
combined therapy of very low doses of R. graveolens and muscimol which were in 
themselves, ineffective, significantly antagonized PTZ-induced tonic convulsion. This  
supports  the  assertion  that  GABA mechanism may be involved in the   anticonvulsant  
activity  of R. graveolens. 
 
In the present study, bicuculline induced tonic convulsion in mice. According to Rang 
et al. (2012), Nicoll (2001) and Lloyd (1985), bicuculline, a potent GABAA receptor 
antagonist, produces its convulsant activity by blocking GABAA receptors and this 
inhibits GABA neurotransmission in the  brain. Phenobarbitone and diazeparn, both 
known to enhance GABA neurotransmission 1n the brain, antagonized bicuculline-
induced tonic convulsion. Similarly, muscimol, a specific GABAA receptor agonist, 
antagonized the tonic convulsion produced by bicuculline. The leaf methanol extract of 
R. graveolens also antagonized bicuculline- induced tonic convulsion. Phenytoin, 
known to exert its antiepileptic effects by blocking sodiwn ion entry into the brain, did 
not antagonize bicuculline-induced tonic convulsion. The combined therapy of very 
low doses of muscimol and leaf methanol extract of the plant species, which when 
given separately, were ineffective against bicuculline-induced convulsion, effectively 
antagonized the tonic convulsion. These findings further support the claim that 
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activation of GABA mechanisms may underpin the anticonvulsant activity of R. 
graveolens. 
 
According to Rang et al. (2012), picrotoxin produces convulsion by blocking GABAA 
receptor-linked chloride ion channel to prevent the entry of chloride ions into the brain 
and thus inhibit GABA neurotransmission.  In this study, picrotoxin produced tonic 
convulsion in mice which was antagonized by phenobarbitone and diazepam, both of 
which are known to enhance GABA neurotransmission in the brain. Muscimol, a 
specific GABAA receptor agonist, known to mimic the effect of GABA at GABAA 
receptors, also effectively antagonized picrotoxin-induced tonic convulsion. The leaf 
methanol extract of R. graveolens also antagonized picrotoxin- induced tonic 
convulsion. However, phenytoin whose anticonvulsant effect depended on its blocking 
of sodium ion entry into the brain, did not affect picrotoxin-induced tonic convulsion. 
The combined therapy of low doses of muscimol and leaf methanol extract of R. 
graveolens, known to be ineffective when given separately, antagonized the tonic 
convulsion produced by picrotoxin. These findings also show that the leaf methanol 
extract of R. graveolens may be enhancing GABA neurotransmission to produce its 
anticonvulsant activity. N-Methyl-DL-aspartic acid (NMDLA) produces its 
anticonvulsant  effects by acting  as a specific agonist at NlvIDA receptors to mimic 
the action of glutamate, the excitatory neurotransmitter  which  also acts at the  same 
receptors in the brain (Rang et al., 2012; Besancon et al., 2008; Chapman and 
Meldium, 1993). In the present study, phenobarbitone and diazepam, both of \Vhich 
are known to enhance GABA neurotransmission in the brain, did not affect   NlvIDLA-
Induced   tonic   convulsion   in   mice. Muscimol, a specific GABAA receptor agonist 
known to mimic the effects of GABA at this receptor, also did not affect the tonic  
convulsion produced by NlvIDLA.  The leaf methanol extract of R. graveolens,  in all 
the  doses used,  did not alter Nlv1DLA-induced  tonic  convulsion. Phenytoin  known  
to  exert  its  anticonvulsant  effect  by blocking sodiwn ion entry into the brain also did 
not alter the tonic convulsion produced by NMDLA. LY233053, a competitive  NlvIDA  
receptor  antagonist, which acts by blocking  the  effect  of  glutamate  at  NlvIDA  
receptor (Borowicz et al., 1996; Madden et al., 1992) effectively antagonized  
NlvIDLA-induced   tonic   convulsion.   The combined   therapy  of   low   doses   of   
muscimol  and LY 233053 which were in themselves ineffective against NlvIDLA-
induced  tonic  convulsion,  did not  affect  the convulsion   produced   by  NlvIDLA.   
This shows that glutamate   mechanisms may not be involved in the anticonvulsant  
activity  of R. graveolens.  In the present study, the phytochemical qualitative analysis 
of the dried leaf extract of R. graveolens revealed the presence of the following    
chemical    components:    saponins,   tannins, cardiac   glycosides,   alkaloids,   
triterpene   steroids   and flavonoids. Abu Safieh et al. (1986), Mimaki et al. (1997) and 
Muazu and Kaita (2008) from their various  studies, have shown the anticonvulsant 
effect of alkaloids. Fwthermore, flavonoids have also been shown to have 
anticonvulsant effect (Ibrahim et al., 2008; Van Heerden et al., 2002).  According  to 
the studies  of Singh et al. (2012) and Chauhan et al. (1988), saponin and triterpene 
steroids also have anticonvulsant effects. Since R. graveolens has been shown to 
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contain alkaloids, flavonoids, saponins and triterpene steroids a111ongst other 
chemical components, it is possible, therefore, that these secondary metabolites may be 
contributing to the anticonvulsant activity of the plant species. 
 
The data obtained from the acute toxicity study carried out showed that following 
oral administration of the leaf methanol extract to mice, the LD50 may be greater than 
4000 mg kg-1. The leaves of R. graveolens are given orally   as an infusion by 
traditional   medicine practitioners (Van Wyk et al., 1997). Therefore, the high LD50 
obtained for the plant species following oral administration indicates  that  it  1s  safe  
in  and non-toxic to the animals. The HPLC fingerprint obtained for R. graveolens 
revealed the presence of characteristics peaks at 350 nm which may be used to identify 
the exact species of the plant. 
 
Conclusion 
The data obtained from this study indicate that the leaf methanol extract of R. 
graveolens has anticonvulsant activity which may be underpinned by enhancement of 
GABA neurotransmission. Secondary metabolites such as saponins, triterpene steroids, 
alkaloids and flavonoids found in the leaves of the plant  species  may  also  in part be 
contributing  to the  anticonvulsant  activity. These findings justify the use of R. 
graveolens by traditional medicine practitioners in the management and treatment of 
epilepsy. However, fwther  studies  are needed to elucidate the full mechanism(s) of 
the anticonvulsant activity of the plant species. Also additional toxicological studies 
are needed to  determine the  safety  profile of R. graveolens. 
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